Adipose Tissue Insulin Resistance in Gestational Diabetes

Batbayar Tumurbaatar, Aaron T. Poole, Gayle Olson, Michel Makhlouf, Hanaa S. Sallam, Shwetha Thukuntla, Sucharitha Kankanala, Obos Ekhaese, Guillermo Gomez, Manisha Chandalia, Nicola Abate

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Gestational diabetes mellitus (GDM) is a metabolic disorder characterized by insulin resistance (IR) and altered glucose-lipid metabolism. We propose that ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1), a protein known to induce adipocyte IR, is a determinant of GDM. Our objective was to study ENPP1 expression in adipose tissue (AT) of obese pregnant women with or without GDM, as well as glucose tolerance in pregnant transgenic (Tg) mice with AT-specific overexpression of human ENPP1. Methods: AT biopsies and blood were collected from body mass index-matched obese pregnant women non-GDM (n = 6), GDM (n = 7), and nonpregnant controls (n = 6) undergoing cesarian section or elective surgeries, respectively. We measured the following: (1) Expression of key molecules involved in insulin signaling and glucose-lipid metabolism in AT; (2) Plasma glucose and insulin levels and calculation of homeostasis model assessment of IR (HOMA-IR); (3) Intraperitoneal glucose tolerance test in AtENPP1 Tg pregnant mice. Results: We found that: (1) Obese GDM patients have higher AT ENPP1 expression than obese non-GDM patients, or controls (P = 0.01 - ANOVA). (2) ENPP1 expression level correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation, and to other adipocyte functional proteins involved in glucose and lipid metabolism (P < 0.05 each), (3) AT ENPP1 expression levels were positively correlated with HOMA-IR (P = 0.01 - ANOVA). (4) Pregnant AT ENPP1 Tg mice showed higher plasma glucose than wild type animals (P = 0.046 - t test on area under curve [AUC]glucose). Conclusions: Our results provide evidence of a causative link between ENPP1 and alterations in insulin signaling, glucose uptake, and lipid metabolism in subcutaneous abdominal AT of GDM, which may mediate IR and hyperglycemia in GDM.

Original languageEnglish (US)
Pages (from-to)86-92
Number of pages7
JournalMetabolic Syndrome and Related Disorders
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

Gestational Diabetes
Phosphoric Diester Hydrolases
Insulin Resistance
Adipose Tissue
Glucose
Lipid Metabolism
Transgenic Mice
Insulin
Adipocytes
Pregnant Women
Diabetes Mellitus
Analysis of Variance
Homeostasis
Abdominal Subcutaneous Fat
Insulin Receptor Substrate Proteins
Wild Animals
Facilitative Glucose Transport Proteins
diphosphoric acid
Glucose Tolerance Test
Cesarean Section

Keywords

  • ENPP1
  • gestational diabetes
  • insulin signaling
  • pregnancy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Tumurbaatar, B., Poole, A. T., Olson, G., Makhlouf, M., Sallam, H. S., Thukuntla, S., ... Abate, N. (2017). Adipose Tissue Insulin Resistance in Gestational Diabetes. Metabolic Syndrome and Related Disorders, 15(2), 86-92. https://doi.org/10.1089/met.2016.0124

Adipose Tissue Insulin Resistance in Gestational Diabetes. / Tumurbaatar, Batbayar; Poole, Aaron T.; Olson, Gayle; Makhlouf, Michel; Sallam, Hanaa S.; Thukuntla, Shwetha; Kankanala, Sucharitha; Ekhaese, Obos; Gomez, Guillermo; Chandalia, Manisha; Abate, Nicola.

In: Metabolic Syndrome and Related Disorders, Vol. 15, No. 2, 01.03.2017, p. 86-92.

Research output: Contribution to journalArticle

Tumurbaatar, B, Poole, AT, Olson, G, Makhlouf, M, Sallam, HS, Thukuntla, S, Kankanala, S, Ekhaese, O, Gomez, G, Chandalia, M & Abate, N 2017, 'Adipose Tissue Insulin Resistance in Gestational Diabetes', Metabolic Syndrome and Related Disorders, vol. 15, no. 2, pp. 86-92. https://doi.org/10.1089/met.2016.0124
Tumurbaatar, Batbayar ; Poole, Aaron T. ; Olson, Gayle ; Makhlouf, Michel ; Sallam, Hanaa S. ; Thukuntla, Shwetha ; Kankanala, Sucharitha ; Ekhaese, Obos ; Gomez, Guillermo ; Chandalia, Manisha ; Abate, Nicola. / Adipose Tissue Insulin Resistance in Gestational Diabetes. In: Metabolic Syndrome and Related Disorders. 2017 ; Vol. 15, No. 2. pp. 86-92.
@article{7f140958be3a44a3a86327c1ada273a2,
title = "Adipose Tissue Insulin Resistance in Gestational Diabetes",
abstract = "Background: Gestational diabetes mellitus (GDM) is a metabolic disorder characterized by insulin resistance (IR) and altered glucose-lipid metabolism. We propose that ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1), a protein known to induce adipocyte IR, is a determinant of GDM. Our objective was to study ENPP1 expression in adipose tissue (AT) of obese pregnant women with or without GDM, as well as glucose tolerance in pregnant transgenic (Tg) mice with AT-specific overexpression of human ENPP1. Methods: AT biopsies and blood were collected from body mass index-matched obese pregnant women non-GDM (n = 6), GDM (n = 7), and nonpregnant controls (n = 6) undergoing cesarian section or elective surgeries, respectively. We measured the following: (1) Expression of key molecules involved in insulin signaling and glucose-lipid metabolism in AT; (2) Plasma glucose and insulin levels and calculation of homeostasis model assessment of IR (HOMA-IR); (3) Intraperitoneal glucose tolerance test in AtENPP1 Tg pregnant mice. Results: We found that: (1) Obese GDM patients have higher AT ENPP1 expression than obese non-GDM patients, or controls (P = 0.01 - ANOVA). (2) ENPP1 expression level correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation, and to other adipocyte functional proteins involved in glucose and lipid metabolism (P < 0.05 each), (3) AT ENPP1 expression levels were positively correlated with HOMA-IR (P = 0.01 - ANOVA). (4) Pregnant AT ENPP1 Tg mice showed higher plasma glucose than wild type animals (P = 0.046 - t test on area under curve [AUC]glucose). Conclusions: Our results provide evidence of a causative link between ENPP1 and alterations in insulin signaling, glucose uptake, and lipid metabolism in subcutaneous abdominal AT of GDM, which may mediate IR and hyperglycemia in GDM.",
keywords = "ENPP1, gestational diabetes, insulin signaling, pregnancy",
author = "Batbayar Tumurbaatar and Poole, {Aaron T.} and Gayle Olson and Michel Makhlouf and Sallam, {Hanaa S.} and Shwetha Thukuntla and Sucharitha Kankanala and Obos Ekhaese and Guillermo Gomez and Manisha Chandalia and Nicola Abate",
year = "2017",
month = "3",
day = "1",
doi = "10.1089/met.2016.0124",
language = "English (US)",
volume = "15",
pages = "86--92",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Adipose Tissue Insulin Resistance in Gestational Diabetes

AU - Tumurbaatar, Batbayar

AU - Poole, Aaron T.

AU - Olson, Gayle

AU - Makhlouf, Michel

AU - Sallam, Hanaa S.

AU - Thukuntla, Shwetha

AU - Kankanala, Sucharitha

AU - Ekhaese, Obos

AU - Gomez, Guillermo

AU - Chandalia, Manisha

AU - Abate, Nicola

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Gestational diabetes mellitus (GDM) is a metabolic disorder characterized by insulin resistance (IR) and altered glucose-lipid metabolism. We propose that ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1), a protein known to induce adipocyte IR, is a determinant of GDM. Our objective was to study ENPP1 expression in adipose tissue (AT) of obese pregnant women with or without GDM, as well as glucose tolerance in pregnant transgenic (Tg) mice with AT-specific overexpression of human ENPP1. Methods: AT biopsies and blood were collected from body mass index-matched obese pregnant women non-GDM (n = 6), GDM (n = 7), and nonpregnant controls (n = 6) undergoing cesarian section or elective surgeries, respectively. We measured the following: (1) Expression of key molecules involved in insulin signaling and glucose-lipid metabolism in AT; (2) Plasma glucose and insulin levels and calculation of homeostasis model assessment of IR (HOMA-IR); (3) Intraperitoneal glucose tolerance test in AtENPP1 Tg pregnant mice. Results: We found that: (1) Obese GDM patients have higher AT ENPP1 expression than obese non-GDM patients, or controls (P = 0.01 - ANOVA). (2) ENPP1 expression level correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation, and to other adipocyte functional proteins involved in glucose and lipid metabolism (P < 0.05 each), (3) AT ENPP1 expression levels were positively correlated with HOMA-IR (P = 0.01 - ANOVA). (4) Pregnant AT ENPP1 Tg mice showed higher plasma glucose than wild type animals (P = 0.046 - t test on area under curve [AUC]glucose). Conclusions: Our results provide evidence of a causative link between ENPP1 and alterations in insulin signaling, glucose uptake, and lipid metabolism in subcutaneous abdominal AT of GDM, which may mediate IR and hyperglycemia in GDM.

AB - Background: Gestational diabetes mellitus (GDM) is a metabolic disorder characterized by insulin resistance (IR) and altered glucose-lipid metabolism. We propose that ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1), a protein known to induce adipocyte IR, is a determinant of GDM. Our objective was to study ENPP1 expression in adipose tissue (AT) of obese pregnant women with or without GDM, as well as glucose tolerance in pregnant transgenic (Tg) mice with AT-specific overexpression of human ENPP1. Methods: AT biopsies and blood were collected from body mass index-matched obese pregnant women non-GDM (n = 6), GDM (n = 7), and nonpregnant controls (n = 6) undergoing cesarian section or elective surgeries, respectively. We measured the following: (1) Expression of key molecules involved in insulin signaling and glucose-lipid metabolism in AT; (2) Plasma glucose and insulin levels and calculation of homeostasis model assessment of IR (HOMA-IR); (3) Intraperitoneal glucose tolerance test in AtENPP1 Tg pregnant mice. Results: We found that: (1) Obese GDM patients have higher AT ENPP1 expression than obese non-GDM patients, or controls (P = 0.01 - ANOVA). (2) ENPP1 expression level correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation, and to other adipocyte functional proteins involved in glucose and lipid metabolism (P < 0.05 each), (3) AT ENPP1 expression levels were positively correlated with HOMA-IR (P = 0.01 - ANOVA). (4) Pregnant AT ENPP1 Tg mice showed higher plasma glucose than wild type animals (P = 0.046 - t test on area under curve [AUC]glucose). Conclusions: Our results provide evidence of a causative link between ENPP1 and alterations in insulin signaling, glucose uptake, and lipid metabolism in subcutaneous abdominal AT of GDM, which may mediate IR and hyperglycemia in GDM.

KW - ENPP1

KW - gestational diabetes

KW - insulin signaling

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85014051410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014051410&partnerID=8YFLogxK

U2 - 10.1089/met.2016.0124

DO - 10.1089/met.2016.0124

M3 - Article

VL - 15

SP - 86

EP - 92

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 2

ER -